World

European powers decry US travel bans

Dec 25, 2025

Washington DC [US], December 25: European powers on Wednesday sharply criticized entry bans imposed by the United States on five Europeans accused of censoring online platforms, warning the move could trigger countermeasures and further strain trans-Atlantic relations.
The US State Department on Tuesday imposed travel bans on former EU commissioner Thierry Breton and four civil society campaigners, including the heads of the German organization HateAid, accusing them of promoting "extraterritorial censorship" of US-based online services.
The European Commission said it "strongly condemned" the sanctions and had requested clarification from Washington. "If needed, we will respond swiftly and decisively to defend our regulatory autonomy against unjustified measures," the commission said, without specifying possible steps.
German Foreign Minister Johann Wadephul called the US measures unacceptable, stressing that the DSA was democratically adopted and applies only within the European Union.
Source: Qatar Tribune

More news

Sirolimus-Coated Balloon Matches Drug-Eluting Stent at One Year in Large International TRANSFORM II Trial

Tampa (Florida) [US], November 2: Sirolimus-coated balloon (SCB) strategy was non-inferior to contemporary everolimus-eluting stents (EES) for Target Lesion Failure (TLF) at 12 months in patients with de novo coronary artery disease. These are the results of the TRANSFORM II randomised trial, presented today as a Late-Breaking Clinical Trial at TCT 2026 and accepted in The Lancet which confirm how MagicTouch Sirolimus Coated Balloon (Concept Medical) matches contemporary best in class stent. Late-breaking results presented at TCT 2026 show an implant-free strategy with MagicTouch Sirolimus Coated Balloon is non-inferior to everolimus-eluting in de novo coronary artery disease.

Nov 02, 2026